Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents

Products	Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents
Company	ABR-Affinity BioReagents
Item	Rat SAP97 Neutralizing Peptide
Price
Description	PEP-055 is a 20 amino acid synthetic peptide whose sequence corresponds to residues 115-133 of rat SAP97. The sequence of this peptide is (amino to carboxy terminus): V115 - L - P - S - E - R - I - S - P - Q - V - P - N - E - V - L - G - P - E133 (C) (The C-terminal cysteine has been added to facilitate conjugation and is not a part of the native rat SAP97 sequence.). This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and SAP97, catalog # PA1-741. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~ 70-fold) for competitive inhibition of antibody-protein binding reactions. Storage: -20 C, Avoid Freeze/Thaw Cycles.
Info	ABR-Affinity BioReagents ABR-Affinity BioReagents Inc. 4620 Technology Drive, Suite 600 Golden, CO 80403 USA Customer Service: +1.800.527.4535 Fax Number: +1.303.278.2424 Web Site: http://www.bioreagents.com

NOTE: Price information is approximate list price and actual prices may vary.

TAG: Rat SAP97 Neutralizing Peptide from ABR Affinity BioReagents

Peptone from Sigma-Aldrich

SmartSpec 3000 Spectrophotometer from Bio-Rad

Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen

BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware

Biology Products:

Peptone from Sigma-Aldrich SmartSpec 3000 Spectrophotometer from Bio-Rad Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware

(Date:11/4/2009)... Heavy traffic corridors in the cities of Long Bea... proportion of preventable childhood asthma, and t... on the disease has likely been underestimated, ac...rn California (USC). , The study, which appears...Public Health , estimated that nine percent of all...

(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 /PRNewswire/ ...d molecular sensing and imaging devices which shed...ay that it has signed exclusive distribution deals... Sensors. The markets covered include Australia, ... (Benelux), Suriname, Italy, France, Spain, Portug...

(Date:11/4/2009)..., CARLSBAD, Calif., Oct. 23 Gen...re biosample management for genomic discovery, med...id Wellis, Ph.D., GenVault,s President and CEO, wi... taking place on October 26th and 27th in La Jolla...ll provide an overview of the company together wit...

Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2 Spectros Signs New International Distribution Deals 2 GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2 A new take on growth factor signaling in tamoxifen resistance 49843 1 A new take on growth factor signaling in tamoxifen resistance 49843 2 Hanger Orthopedic Group Inc Announces Second Quarter 2009 Earnings Release Conference Call 49840 1 Pelosi 3A We Are Leading the Way in Creating a Healthier America by Strengthening Health Care for Our Veterans 49837 1

[0] USC study finds big air pollution impacts on local communities [0] Spectros Signs New International Distribution Deals [0] GenVault Corporation to Present at the 2009 BIOCOM Investor Conference

... University researchers will use a $4 million gran...the functions of genes in a plant - research which...th and agriculture. , In a collaborative effort sp...termine the functions of roughly 4,400 nuclear gen...owering plant whose entire 29,000 gene sequence is...

...pox in the United States during the summer of 2003... disease usually kills 10 percent of those infecte...ch from Saint Louis University Health Sciences Cen...n answer. , In this month,s issue of Virology, res... Saint Louis University Health Sciences Center and...

...selective logging stopped in the region now known ...uenon (Cercophithecus ascanius) is a primate still...rt in a new study, changed the ecological balance ...nd opening the door for multiple parasitic infecti...ecies, collecting 1,076 fecal samples from the hea...

Other Biology News:MSU researchers receive $4 million grant to uncover gene functions 2 Monkeypox mystery: New research may explain why 2003 outbreak in the US wasn't deadly 2 President Bush's cut to AIDS prevention in Africa would be devastating 2 President Bush's cut to AIDS prevention in Africa would be devastating 3

MSU researchers receive $4 million grant to uncover gene functions Monkeypox mystery: New research may explain why 2003 outbreak in the US wasn't deadly President Bush's cut to AIDS prevention in Africa would be devastating

(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...

(Date:11/5/2009)... , TRANSPORTATION -- Gone hybrid . . . , Fue...mobiles are now posted at the www.fueleconomy.gov...veloped and maintains for the U.S. Department of E.... Nine of the top 10 vehicles on the best fuel eco...Prius (51 MPG city; 48 highway). "This list proves...

(Date:11/5/2009)...,, PARSIPPANY, N.J., Nov. 5 DSM...as made a manufacturing alliance with Galenix, Sai...ferred commercial scale manufacturing partner for ..., DSM and Galenix will collaborate on business de...delivery technologies, based on the strength of Ga...

(Date:11/5/2009)...,, Conference Call on Thursday, November 5, 200... VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGen...any") (NASDAQ: OGXI ) today reported unaudited fi...ths ended September 30, 2009 and reviewed the Comp..., The following consolidated results reflect the...

Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2 Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3 November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2 November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3 DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2 DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3 OncoGenex Reports Third Quarter 2009 Financial Results 2 OncoGenex Reports Third Quarter 2009 Financial Results 3 OncoGenex Reports Third Quarter 2009 Financial Results 4 OncoGenex Reports Third Quarter 2009 Financial Results 5 OncoGenex Reports Third Quarter 2009 Financial Results 6 OncoGenex Reports Third Quarter 2009 Financial Results 7 OncoGenex Reports Third Quarter 2009 Financial Results 8

[0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix [0] OncoGenex Reports Third Quarter 2009 Financial Results